Company Active LTD

Company profile

Clin-E-Cal LTD.

UK company 09346983, incorporated on 9 December 2014.

Clin-e-cal

Clin-E-Cal LTD. is a UK company with status active founded in 2014 based in North West England.

Company number
09346983
Incorporated
9 Dec 2014
Companies House status
Active

Company identity

Founded / incorporated
9 December 2014

Company number 09346983

Verify at Companies House
Legal name
CLIN-E-CAL LTD.
Company type
LTD
Region
North West England
Registered address
Unknown
Insolvency history
No

Corporate ownership

Updated 07 Jul 2026 09:49

11 levels 2 ultimate controllers
1
Company Active LTD
Clin-E-Cal LTD.
CRN 09346983
2
Direct controller Active LLP
3
Intermediate controller Active LTD
4
Intermediate controller Active LTD
5
Intermediate controller Active LTD
6
Ultimate controller Active LTD
7
Intermediate controller Active LLP
Barnett Waddingham LLP
CRN OC307678
8
Intermediate controller Active LTD
9
Intermediate controller Active LTD
10
Intermediate controller Active LTD
11
Intermediate controller Active LTD
HGH Midco 3 Limited
CRN 13646017
12
Intermediate controller Active LTD
Hig Finance 2 Limited
CRN 10842605
13
Intermediate controller Active LTD
HGH Finance Limited
CRN 13645436
14
Intermediate controller Active LTD
HGH Midco 2 Limited
CRN 13644440
15
Intermediate controller Active LTD
HGH Midco 1 Limited
CRN 13642978
16
Ultimate controller Active LTD

Latest accounts

Financial period: 1 Jan 2024 to 31 Dec 2024

FILLETEDACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
1

Company events

Reference milestones and recent Companies House filing stream events.

1 event
09 Dec
2014

Incorporated

Inception

Company registered at Companies House

Public funding

3 awards
First funded
2015
Funded years
2015, 2019
Age at first award
0 years

Projects

2019 Collaborative R&D Lead participant

Development of a non-bluetooth smart inhaler.

1 Feb 2019 to 31 Jan 2020

Awarded
£133,925
Total cost £297,610

People with respiratory diseases, including asthma and COPD are usually treated with inhaler medication. This medication is designed for two purposes - preventing the disease symptoms day to day and treating incidences of worsening symptoms known as exacerbations. If a patient fails to take the preventer inhaler regularly or it is taken incorrectly, this ...

2015 SME Support Lead participant

Clin-e-cal Ltd(add onto 700565)

1 Dec 2015 to 29 Feb 2016

Awarded
£600
Total cost £600

Awaiting Public Project Summary

2015 GRD Proof of Market Lead participant

Rafi-tone: Market testing resubmission

1 Jul 2015 to 31 Dec 2015

Awarded
£24,930
Total cost £41,550

Viral induced wheeze or chronic wheeze associated with asthma affects 5.5 million children under 5 in Europe and the US. Our company, Clin-e-cal Ltd, has developed Rafi-tone, an innovative device which has been created to aid compliance of young children to inhaler medication delivered via a spacer device. Rafi-tone addresses two problems: in the short te...

Product types

Collaborative R&D GRD Proof of Market SME Support